Table 3 Efficacy evaluation of tumor response in the three groups at 3 months of treatment
Group | Chi-square test (p-value) | |||||
|---|---|---|---|---|---|---|
Control group | ETV group | TDF group | Pearson Chi-Square | |||
Response evaluation | CR | Count(%) | 10(4.7%) | 19(8.6%) | 25(11.0%) | 0.010 |
PR | Count(%) | 52(24.5%) | 100(45.5%) | 119(52.1%) | ||
SD | Count(%) | 73(34.5%) | 59(26.8%) | 57(25.0%) | ||
PD | Count(%) | 77(36.3%) | 42(19.1%) | 27(11.9%) | ||
ORR | Count(%) | 62(29.2%) | 119(54.1%) | 144(63.2%) | 0.001 | |
DCR | Count(%) | 135(63.7%) | 178(80.9%) | 201(88.1%) | 0.002 | |